Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.

[1]  Kutty Selva Nandakumar,et al.  Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells. , 2005, Arthritis and rheumatism.

[2]  Kutty Selva Nandakumar,et al.  A genetic contamination in MHC‐congenic mouse strains reveals a locus on chromosome 10 that determines autoimmunity and arthritis susceptibility , 2005, European journal of immunology.

[3]  Kutty Selva Nandakumar,et al.  The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. , 2005, The American journal of pathology.

[4]  Kutty Selva Nandakumar,et al.  Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells , 2004, Arthritis research & therapy.

[5]  Kutty Selva Nandakumar,et al.  Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis , 2004, Annals of the rheumatic diseases.

[6]  R. Holmdahl,et al.  Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Rowley,et al.  An arthritogenic monoclonal antibody to type II collagen, CII‐C1, impairs cartilage formation by cultured chondrocytes , 2004, Immunology and cell biology.

[8]  Kutty Selva Nandakumar,et al.  Antileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis. , 2004, Arthritis and rheumatism.

[9]  A. Minami,et al.  Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). , 2004, Cytokine.

[10]  Kutty Selva Nandakumar,et al.  Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis , 2004, European journal of immunology.

[11]  M. Rowley,et al.  Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro. , 2004, JIM - Journal of Immunological Methods.

[12]  Kutty Selva Nandakumar,et al.  Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. , 2003, The American journal of pathology.

[13]  Kutty Selva Nandakumar,et al.  Induction of arthritis by single monoclonal IgG anti‐collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcγRIIB , 2003, European journal of immunology.

[14]  S. Ziegler,et al.  CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. , 2003, International immunology.

[15]  H. Inoue,et al.  Effect of NOS2 gene deficiency on the development of autoantibody mediated arthritis and subsequent articular cartilage degeneration. , 2003, The Journal of rheumatology.

[16]  Kutty Selva Nandakumar,et al.  IL‐4‐deficient mice develop less acute but more chronic relapsing collagen‐induced arthritis , 2002, European journal of immunology.

[17]  Kutty Selva Nandakumar,et al.  Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. , 2002, Arthritis and rheumatism.

[18]  Shigeyoshi Itohara,et al.  The Role of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Antibody-Induced Arthritis , 2002, The Journal of Immunology.

[19]  T. Kagari,et al.  The Importance of IL-1β and TNF-α, and the Noninvolvement of IL-6, in the Development of Monoclonal Antibody-Induced Arthritis , 2002, The Journal of Immunology.

[20]  C. Benoist,et al.  Arthritogenic Monoclonal Antibodies from K/BxN Mice , 2002, The Journal of experimental medicine.

[21]  M. Noda,et al.  Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Karin,et al.  Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. , 2002, Arthritis and rheumatism.

[23]  Kutty Selva Nandakumar,et al.  IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies1 , 2001, The Journal of Immunology.

[24]  R. Holmdahl,et al.  Identification of conformation-dependent epitopes and V gene selection in the B cell response to type II collagen in the DA rat. , 2001, International immunology.

[25]  R. Holmdahl,et al.  Cartilage‐specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin‐binding‐domain of collagen type II , 2001, European journal of immunology.

[26]  E. Sasatomi,et al.  Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritisin mice , 2000, Immunology.

[27]  R. Holmdahl,et al.  Collagen-induced arthritis development requires αβ T cells but not γδ T cells: studies with T cell-deficient (TCR mutant) mice , 1999 .

[28]  K. L. Donaldson,et al.  Regulation of inflammatory responses by oncostatin M. , 1999, Journal of immunology.

[29]  K. Rajewsky,et al.  From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. , 1999, Immunity.

[30]  C. Berek,et al.  Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. , 1999, Journal of immunology.

[31]  R. Holmdahl,et al.  B cell‐deficient mice do not develop type II collagen‐induced arthritis (CIA) , 1998, Clinical and experimental immunology.

[32]  R. Holmdahl,et al.  Arthritis-related B Cell Epitopes in Collagen II Are Conformation-dependent and Sterically Privileged in Accessible Sites of Cartilage Collagen Fibrils* , 1998, The Journal of Biological Chemistry.

[33]  R. Holmdahl,et al.  The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift. , 1996, Journal of immunology.

[34]  H. Miyahara,et al.  Induction by chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coli lipopolysaccharide. , 1996, British journal of rheumatology.

[35]  C. Berek,et al.  Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Holmdahl,et al.  Binding of autoreactive mouse anti-type II collagen antibodies derived from the primary and the secondary immune response investigated with the biosensor technique. , 1995, Journal of immunological methods.

[37]  R. Holmdahl,et al.  Expression of a transgenic class II Ab gene confers susceptibility to collagen‐induced arthritis , 1994, European journal of immunology.

[38]  R. Holmdahl,et al.  Germline‐Encoded IgG Antibodies Bind Mouse Cartilage In Vivo: Epitope‐ and Idiotype‐Specific Binding and Inhibition , 1994, Scandinavian journal of immunology.

[39]  A. Kang,et al.  Induction of arthritis with monoclonal antibodies to collagen. , 1992, Journal of immunology.

[40]  L. Klareskog,et al.  Origin of the autoreactive anti-type II collagen response. II. Specificities, antibody isotypes and usage of V gene families of anti-type II collagen B cells. , 1989, Journal of immunology.

[41]  R. Jonsson,et al.  Demonstration of immunoreactive sites on cartilage after in vivo administration of biotinylated anti-type II collagen antibodies. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  H. Fujiwara,et al.  Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. , 1988, Journal of immunology.

[43]  L. Klareskog,et al.  Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. , 1986, Arthritis and rheumatism.

[44]  H. Luthra,et al.  Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. , 1984, Mayo Clinic proceedings.

[45]  F. Dixon,et al.  Serum transfer of collagen-induced arthritis in mice , 1983, The Journal of experimental medicine.

[46]  A. Kang,et al.  Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis , 1982, The Journal of experimental medicine.

[47]  H. Luthra,et al.  Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates , 1981, The Journal of experimental medicine.

[48]  T. Kagari,et al.  The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. , 2002, Journal of immunology.

[49]  R. Holmdahl,et al.  Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice. , 1999, International immunology.

[50]  Kenneth W. Adolph,et al.  Human genome methods , 1998 .

[51]  J. Seyer,et al.  Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. , 1995, Autoimmunity.

[52]  R. Jonsson,et al.  Multiple epitopes on cartilage type II collagen are accessible for antibody binding in vivo. , 1991, Autoimmunity.